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Objective: This report elucidates the long-term safety and effectiveness of extended
aortic arch replacement with an open stent-grafting technique from our 12 years of
experience.
Methods: From 1994 to 2004, 126 patients (mean age 67.8 years) with different path-
ologic conditions of the aortic arch with extension to the descending aorta (57 dissec-
tions [acute/chronic 5 31/26] and 69 aneurysms) were operated on with an open
stent-grafting technique. During deep hypothermic circulatory arrest with selective
cerebral perfusion, the stent graft was delivered through the transected proximal aortic
arch, and arch replacement with a 4-branched prosthesis was performed.
Results: Operative mortality within 30 days was 3.2%. Perioperative morbidity in-
cluded 7 (5.6%) strokes and 8 (6.3%) spinal injuries (paraplegia in 3, transient para-
paresis in 5). Sixty-three percent of the patients were extubated within 24 hours. In
long-term follow-up (mean 60.4 6 36.5 months, maximum 153 months), survival
was 81.1%, 63.3%, and 53.7% at 1, 5, and 8 years. Five (3.9%) late endoleaks
were observed but treated with successful additional endovascular repair. Freedom
from endoleaks was 98.0%, 91.1%, and 91.1% for 1, 5, and 8 years, respectively.
Conclusion: Long-term observation showed safety and good durability of the open
stent-grafting technique for aortic arch disease. This technique could be an attractive
treatment option for aortic arch aneurysm with distal extension and aortic dissection
requiring aortic arch replacement.
D
irect surgical approach to pathologic conditions of the aortic arch has been
a time-tested, established procedure with satisfactory results and durability.
Median sternotomy is the preferred and most advantageous approach. How-
ever, performing anastomosis and hemostasis at the deep portion beyond the left sub-
clavian artery is often associated with difficulties and also could induce recurrent
laryngeal nerve injury. Moreover, when the distal end of the disease extends to the
descending aorta, surgeons have to select extensive exposure of the distal aortic
arch or left thoracotomy, which could raise the risk of respiratory complications.
Several approaches such as the clamshell incision,1 median sternotomy with left
thoracotomy,2 and 2-stage repair with elephant trunk3,4 have been applied in this
situation, but a less invasive procedure without left thoracotomy and with completion
in a single stage is desired.
Meanwhile, as an emerging, less invasive alternative to conventional surgical
repair, thoracic endovascular aortic repair (TEVAR) was brought into clinical use
by Dake and his colleagues5 and reported in 1994. Our group has also been using
TEVAR since 1993 after animal experimentation,6,7 and satisfactory early outcomes
were achieved for type B aortic dissection.8 This method yielded a less invasive alter-
native for high-risk patients. However, applying TEVAR to aortic arch diseases was
difficult because the aortic arch could not provide an adequate proximal landing zone.
To mitigate the difficulties in both the distal anastomosis in conventional arch surgery
and the proximal landing zone in TEVAR for the aortic arch, our group9 introduced
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CSFD 5 cerebrospinal fluid drainage
CT 5 computed tomography
TEVAR 5 thoracic endovascular aortic repair
Th 5 thoracic (vertebra)
the open stent-grafting technique in 1994. This technique,
which subsequently has been described as frozen elephant
trunk technique or stented elephant trunk in some
articles,10-14 involves conventional replacement of the as-
cending aorta with a 4-branched graft and stent grafting
into the descending aorta through the opened aortic arch. In
2002, we15 reported that this technique is feasible for aortic
dissection to obtain clot formation and shrinkage of the false
lumen by closing the entry site in the aortic arch and provid-
ing continuous compression on the false lumen.
Previous reports10-15 described relatively small series, and
it is still controversial whether this technique is safe and
useful for long-term results.
The objective of this current report is to elucidate the
feasibility of this technique for extended aortic arch replace-
ment and to investigate the long-term durability and efficacy
of this hybrid procedure from our 12 years of experience.
Patients and Methods
Patients
The open stent-grafting technique and the retrospective review of
the records for publication were approved by the institutional review
board. From February 1994 to July 2004, 126 patients having path-
ologic conditions of the aortic arch with extension to the descending
aorta were operated on in a single center (Osaka General Medical
Center, Osaka Prefectural Hospital) by an open stent-grafting tech-
nique. The selection for open stent-grafting technique was aortic
arch aneurysms with extension to the descending aorta or aortic dis-
sections that necessitated aortic arch replacement. These indications
are listed as follows:
Aortic Arch/Proximal Descending Aortic Aneurysms
 Involving proximal portion of left subclavian artery and
unable to be treated with TEVAR
 Extending distally to descending aorta and difficult/
unable to perform distal anastomosis in median approach
 Expected tight adhesion around distal anastomosis site
(eg, redo operation)
Aortic Dissection
 Type A dissection with intimal tear in transverse arch or
proximal descending aorta that could not be resected by
hemiarch replacement
 Type A/type B dissection with aortic arch enlargement/
aneurysm
 Type B dissection with intimal tear in root of left subcla-
vian artery (unable to close with TEVAR)
Informed consent was required in each case. Mean patient age
was 67.8 years (range, 35–85 years), and 14 (11.1%) patients
were older than 80 years. Thirty-seven (29.3%) operations were of1262 The Journal of Thoracic and Cardiovascular Surgery c Juan emergency status. Preoperative comorbidities are shown in Table
1. Ten (7.9%) patients had previous graft replacement of descending
or thoracoabdominal aorta, and 18 (14.3%) had a history of abdom-
inal aortic repair. There were 3 (2.4%) patients with Marfan syn-
drome.
Fifty-seven (46.8%) patients had aortic dissection: among these
patients, 29 (49.2%) had acute type A dissections involving malper-
fusion of organs in 10 and loss of conscious in 3. Twelve (24.4%) of
the dissections were chronic type A dissections, including 5 redo
cases with enlargement of patent false lumen of the aortic arch after
ascending aorta replacement in the acute phase. Sixteen (30.5%)
cases were type B dissections, involving 2 acute complicated cases
and 14 chronic type B dissections with enlargement of the false
lumen (average size 50.0 6 7.7 mm, range 41–70 mm). Sixty-
nine (53.2%) were degenerative/atherosclerotic aneurysms with 9
(13.4%) instances of rupture. The average diameter of the aneurysm
was 63.6 6 10.6 mm. All these aneurysms had distal extension to
the descending aorta, which required stent graft delivery to the level
of the sixth thoracic vertebra (Th6) in 21.4%, Th7 in 35.4%, and
distally to Th8 in 44.2%.
Description of the Device
The stent graft was custom-made. It was composed of a Gianturco
stent (WilliamCookEuropeA/S, Bjaeverskov, Denmark) and a non-
coated polyester fabric graft (WSL graft, Ube, Japan). The diameter
of the polyester graft was selected with the measurement results of
TABLE 1. Preoperative patients profiles
Demographic
Gender (M/F) 86 / 40
Age (mean) 67.8
.80 y 14
Pathology
Degenerative/atherosclerosis 69
Aortic dissection 57
Type A (acute/chronic) 41 (29/12)
Type B (acute/chronic) 16 (2/14)
Diameter of aneurysm (mm) 63.6 6 10.6
Preoperative comorbidities (%)
Stroke 21 (16.7)
Coronary artery disease 28 (22.2)
Low LVEF (,40%) 5 (4.0)
Chronic obstructive pulmonary disease 10 (7.9)
Renal failure (crn . 1.5 mg/dL) 17 (13.5)
History of cancer 9 (7.1)
Previous surgery (%)
Cardiovascular 6 (4.8)
Descending aorta 10 (7.9)
Abdominal aorta 18 (14.3)
Preoperative status
Emergency (%) 37 (29.4)
Malperfusion with aortic dissection
Cerebral artery 3
Coronary artery 4
Visceral artery 3
Lower extremity 7
LVEF, Left ventricular ejection fraction.ne 2008
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eter of the landing zone was calculated by tracing the intimal
circumference, and a graft oversized by 10% to 20% was selected.
These methods were described in detail in a previous study.9 Aver-
age diameter of the stent graft was 25.9 6 3.5 mm for dissections
and 29.5 6 3.2 mm for degenerative aneurysms. We first used
the 30F sheath and pushing rod to deliver the stent graft into the
descending aorta. Although this method did not fail to deploy
the stent graft, inserting the rigid sheath into the descending aorta
under the guidance of transesophageal echocardiography is not
easy. In 2001 we developed a sheathless delivery method. The stent
graft was mounted on a balloon catheter (20F silicone nephrostomy
balloon catheter) and the stented portion was restrained by a silk
string. After the stent graft had been inserted into the descending
aorta through the transected aortic arch, withdrawal of the restrain-
ing string released the self-expandable stented part of the graft.
Surgery
The details of the operation have been described in previous
reports.9,15 Via a median sternotomy, the ascending aorta, brachio-
cephalic artery, and left common carotid artery were dissected. The
arterial return cannula was placed in the right axillary artery and
femoral artery. Cardiopulmonary bypass was initially started with
right axillary perfusion. During core cooling to a 24C bladder
temperature, reconstruction of the left subclavian artery, left com-
mon carotid artery, and proximal anastomosis of the 4-branched
graft was performed (Figure 1, A). The left subclavian artery was re-
constructed in an extramediastinal fashion at the left infra subclavian
space, with the graft branch passing through the second intercostal
space. The proximal end of the 4-branched graft was anastomosed
to the ascending aorta after cardiac arrest was achieved by cross-
clamping the ascending aorta and antegrade administration of cardi-
oplegic solution. Selective cerebral perfusion via the 4-branched
graft and right axillary artery was established and the perfusion to
the lower body was discontinued. The aortic arch was transectedThe Journal of Thorat a predetermined line between the brachiocephalic artery and left
common carotid artery, and the stented portion of the stent graft
was inserted to the descending aorta (Figure 1, B). After deploy-
ment, the stented portion was dilated with a balloon catheter under
the guidance of transesophageal echocardiography to confirm that
the stent graft was fully opened and not kinked. The nonstented graft
portion was sutured to the transected stump of the aortic arch, and
subsequently continuous anastomosis to the 4-branched graft was
made in end-to-end fashion. The debris and air were carefully
flushed out from the descending aorta with femoral blood return
before this anastomosis was completed. During rewarming, the bra-
chiocephalic artery was reconstructed and the procedure was com-
pleted (Figure 1, C). When the ascending aorta was intact and
replacement was unnecessary, a bifurcated graft was anastomosed
to the ascending aorta instead of 4-branched graft replacement.
Reconstruction of the left common carotid artery and left subclavian
artery was performed in the same fashion. To prevent ischemic spi-
nal injury, when the time of lower body circulatory arrest extended
over 30 minutes, blood return to lower body was established from
femoral artery with occluding the stent graft by balloon catheter.
Spinal Protection
From January 1997, cerebrospinal fluid drainage (CSFD) was
performed before the operation in elective cases with a history of
aortic repair in the thoracoabdominal or abdominal aorta. CSFD
was administered preoperatively in 16 (12.7%) cases. When the
pathologic condition required stent graft delivery lower than the
ninth thoracic vertebra, a short stent graft was delivered in the
descending aorta without excluding the aneurysm, and additional
endovascular grafting was performed the next day for complete ex-
clusion (delayed exclusion technique). From 2001, to avoid spinal
cord ischemia, we started to apply the delayed exclusion technique
because of the following reasons:
1. Technical reason. A longer stent graft is hard to control un-
der the guidance of transesophageal echocardiography, andFigure 1. A, reconstruction of the left subclavian artery, left common carotid artery, and proximal anastomosis of the
4-branched graft. B, The aortic arch was transected at a predetermined line between the brachiocephalic artery and
left common carotid artery, and the stent graft was inserted to the descending aorta. C, The brachiocephalic artery
was reconstructed and the procedure was completedacic and Cardiovascular Surgery c Volume 135, Number 6 1263
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manageable length of the stent graft is less than 15 cm,
and this could reach around Th8 level.
2. Preservation of the spinal circulation. TEVAR provides
excellent avoidance of spinal cord ischemia even when it
covers the major intercostal artery connecting to the anterior
spinal artery (Adamkiewicz artery). Delayed exclusion with
additional endovascular grafting could maintain the spinal
circulation, and we anticipate this technique could decrease
the risk of spinal cord ischemia. Six (4.8%) patients were
treated with the delayed exclusion technique.
Patient Follow-up
The follow-up with contrast CT imaging was obtained before hospi-
tal discharge, 6 months after the operation, and yearly thereafter. A
follow-up CT image was available for 81.9% of patients who
survived longer than 6 months. Follow-up clinical status was ob-
tained by medical records from an outpatient clinic or by contacting
surviving patients or family members and primary care physician.
Follow-up was 92.6% complete, averaging 60.4 6 36.5 months
(maximal follow-up 153 month, total cumulative follow-up 5 533
patient-years; 45 patient remaining at risk at 5 years).
Statistical Analysis
All data were reviewed retrospectively. Continuous variables are ex-
pressed as mean6 SD and categorical variables as percentages. Sur-
vival and freedoms from aortic arch–related death, freedom from
endoleaks, freedom from aortic intervention, and freedom from ma-
jor adverse events were estimated by the Kaplan–Meier method.
Results
Early Outcome
The stent graft delivery was technically successful in all 126
patients. In 6 (4.8%) patients kinking of the stent graft
showed a pressure gradient greater than 20 mm Hg. All these
patients were successfully treated intraoperatively by endo-
vascular repair with additional bare stent deployment.
Concomitant procedures included 4 aortic root replacements,
6 aortic valve replacements, and 8 coronary artery bypass
grafts. There were 7 cases of type A acute aortic dissection
with malperfusion of the lower extremity. To recanalized
the malperfusion, we performed endovascular repair in 4 pa-
tients (3 iliac stenting and 1 stenting of the descending aorta)
and bypass grafting in 3 (2 aortofemoral bypass and 1 femo-
rofemoral bypass) intraoperatively. The average operative,
cardiopulmonary bypass, and circulatory arrest times of the
lower body were 401, 147, 31 minutes, respectively.
Operative mortality within 30 days was 4 of 126 (3.2%).
Two death were in acute type A dissection (1 due to postoper-
ative heart failure, 1 due to uncontrollable hemmorage from
the aortic root with coagulopathy), and another 2 death were
in degenerative aneurysm (1 due to stroke, 1 due to postoper-
ative thoracoabdominal aneurysm rupture). There were 7 in-
hospital deaths after 30 days (in-hospital mortality 5.5%).
The causes of in-hospital mortality were brain infarction
(n5 1), sepsis (n5 3), aortoesophageal fistula (n5 1), rupture1264 The Journal of Thoracic and Cardiovascular Surgery c Juof thoracoabdominal aortic aneurysm (n5 1), and acute myo-
cardial infarction (n5 1). Aortoesophageal fistula occurred in
a patient with ruptured type B aortic dissection with mediasti-
nal hematoma. This patient was treated successfully with the
open stent-grafting technique and the aneurysm was success-
fully excluded, but an aortoesophageal fistula developed after
the mediastinal hematoma had absorbed at 38 days postoper-
atively. The causes of early deathwithin 1 year are listed in Ta-
ble 2. Perioperative morbidity included 7 (5.6%) strokes, 3
(2.4%) cases of paraplegia, and 5 (3.9%) cases of transient par-
aparesis. No spinal cord ischemia was observed in the patients
treated by the delayed exclusion technique. The average num-
ber of packed red blood cells transfusionswas 14.06 3.1 units
and re-exploration for bleeding was required in 3 (2.4%) pa-
tients. In 6 (4.8%) with renal failure, transient hemodialysis
was required. The length of stay in the intensive care unit
ranged from 0 to 60 days, median 4 days.
Postoperative hoarseness occurred in 12 (9.5%) patients;
however, 7 (58%) of 12 were fully recovered before hospital
discharge. Sixty-three percent of the patients were extubated
within 24 hours, and 8 (6.3%) required tracheostomy.
The demographics of patients with paraplegia and
transient paraparesis are shown in Table 3. All patients
with transient paraparesis had recovered enough to be able
to walk by themselves. The median hospital stay was 29
days, and 11 (8.7%) of the patients were discharged to an
institution for rehabilitation.
Late Outcome
Survival. Actuarial survival estimates 1, 5, and 8 years
after the procedure were 81.1%, 63.3%, and 53.7%, respec-
tively (Figure 2). Causes of deaths are listed in Table 2. There
TABLE 2. Causes of early and late death
Causes of death Early (<1 y) Late (>1 y) Total
Aortic
Rupture (treatment failure) 0 1 1
Aortoesophageal fistula 1 1 2
Rupture of other aortic aneurysm 3 1 4
Nonaortic
Cancer 0 7 7
Brain infarction 3 2 5
Subarachnoid hemorrhage 1 1 2
Pneumonia 0 6 6
Sepsis 3 1 4
Renal failure 1 2 3
Acute myocardial infarction 1 1 2
Arrhythmia 0 1 1
Ischemic colitis 0 1 1
Ileus 0 1 1
Gastric bleeding 0 1 1
Cirrhosis 1 0 1
Suicide 1 0 1
Sudden death 1 0 1ne 2008
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Spinal cord ischemia Pathology Distal landing zone Risk factor Comment
Paraplegia TAA Th8 AAA repair
Paraplegia AD(A) Th6 Hypotension Stent graft stenosis
Parapleiga AD(A) Th6 Hypotension Stent graft stenosis
Transient paraparesis TAA Th9 AAA repair
Transient paraparesis TAA Th8 AAA repair
Transient paraparesis TAA Th8
Transient paraparesis AD(A) Th6 Hypotension Preoperative
malperfusion
Transient paraparesis AD(A) Th6 Hypotension Preoperative
malperfusion
TAA, Degenerative/atherosclerotic aneurysm; AD(A), aortic dissection (type A); AAA. abdominal aortic aneurysm.A
CDwas 1 (0.79%) late death resulting from rupture of a treated
aortic arch aneurysm that was caused by leaking from the
proximal suture site of the stent graft. One (0.8%) late fatal
aortoesophageal fistula had occurred. This case involved
a huge degenerative aneurysm encompassing the whole tho-
racic aorta with chest pain and a hematoma around the aneu-
rysm (sealed rupture). This patient was treated successfully
by extended aortic arch replacement with the open stent-
grafting technique; the stent graft was delivered to the 11th
thoracic vertebra level by a delayed exclusion technique.
The patient had an uneventful recovery, and CT 12 months
after the procedure showed shrinkage of the aneurysm (70
mm to 61 mm). However, 28 months after the procedure,
CT showed type III endoleak. Additional TEVAR was
planned, but the aorta ruptured before treatment was insti-
tuted. Emergency TEVAR could have saved the patient’s
life, but fatal aortoesophageal fistula had occurred.
Brain infarctions as the cause of death within 1 year were
promoted by the surgery, unfortunately. Two late brainThe Journal of Thorainfarctions were observed, but neither of them resulted
from cerebral graft occlusion or graft thrombosis. Rupture
of other aortic aneurysms had occurred while one of the pa-
tients was waiting for the next operation; the other patient
had refused further treatment. All these patients showed com-
plete exclusion of the treated arch aneurysm on postoperative
CT scans, and none of these were associated with stent graft
dislodgment or perforation.
Operative mortality, aortoesophageal fistula, stent graft–
related mortality (perforation, occlusion, and thromboembo-
lism), and cerebral graft–related mortality were defined as
aortic arch–related death, and the freedom from aortic
arch–related death was 95.8%, 92.4%, and 92.4% at 1, 5,
and 8 years, respectively (Figure 3).
Endoleaks and aortic intervention. Follow-up CT was
obtained in 81.9% of patients who survived longer than
6 months. In degenerative aneurysms, 68.3% of the aneu-
rysms showed disappearance or shrinkage in late follow-
up. In aortic dissections, 78.6% have achieved shrinkage of168144120967248240
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Figure 3. Freedom from aortic arch–related death.cic and Cardiovascular Surgery c Volume 135, Number 6 1265
Surgery for Acquired Cardiovascular Disease Shimamura et al
A
CDthe false lumen. Among these patients, 30.3% showed
complete disappearance of the false lumen in the entire aorta,
and 48.4% showed disappearance of the false lumen in the
thoracic lesion. Creation of a new intimal tear by the edge
of the stent graft was not observed in any case.
Late endoleaks were observed in 5 (3.9%) cases (4 in
degenerative/atherosclerotic aneurysms, 1 in chronic type B
aortic dissection). Type I endoleak from the distal end of
the stent graft had occurred in 3 cases, and type III endoleak
from the stent-in-stent site in 2 cases. Endoleaks were
observed an average of 24.8 months postoperatively, and
all of themwere successfully treated with additional endovas-
cular repair. Actuarial freedom from endoleaks was 98.0%,
91.1%, and 91.1% for 1 year, 5 years, and 8 years,
respectively.
Intervention of another aortic lesion was administered in
10 (7.9%) cases. There were 7 TEVARs and 3 graft replace-
ments (1 thoracoabdominal aortic aneurysm and 2 aascend-
ing aortic aneurysms). All of these cases that required
intervention for other aortic lesions were aortic dissection
cases. The average postoperative duration for intervention
of other aortic lesions was 38.3 months (range 3–89 months).
Actuarial freedom from aortic intervention (freedom from in-
tervention of endoleaks and other aortic aneurysms) was
97.2%, 83.8%, and 75.4% for 1, 5, and 8 years, respectively.
Major adverse events. In-hospital death, stroke, spinal
cord ischemia, aortic rupture, aortoesophageal fistula, and
endoleak were defined as major adverse events, and the free-
dom from major adverse events was 79.9%, 73.8%, and
73.8% at 1, 5, and 8 years, respectively.
Discussion
The open stent-graft technique is a hybrid procedure that
combines conventional aortic surgery and endovascular re-
pair. By using the stent graft as an alternative to the distal
anastomosis, surgeons can avoid extended dissection of the
distal arch and left thoracotomy. This procedure could be
completed by making the distal aortic incision between the
brachiocephalic artery and left common carotid artery, which
provides a better surgical view and hemostasis than tradi-
tional anastomosis in aortic arch replacement. Insertion of
the stent graft could be performed in a few minutes. Thus
this procedure has an advantage in arch aneurysms
extending distally to the descending aorta, it being difficult
or impossible to perform distal anastomosis by the median
approach, or in aneurysms that are expected to have tight ad-
hesion around the distal anastomosis site (eg, redo cases). It is
also useful for type A dissections with an intimal tear in the
transverse arch or proximal descending aorta that cannot be
resected by hemiarch replacement.
In this cohort of 126 patients, the overall operative mortal-
ity within 30 days was 3.2%. In degenerative aneurysms, the
operative mortality within 30 days was 2.9%. This is compa-
rable with the operative mortality within 30 days of the first-1266 The Journal of Thoracic and Cardiovascular Surgery c Justage operation with the elephant trunk technique in contem-
porary reports (2.1%–12%).16,17 However, the elephant trunk
technique requires a second-stage operation (mortality 4%–
8.5%) to complete the procedure, and there are even a consid-
erable number of patients who do not survive to the second
operation. The open stent-grafting technique has an advan-
tage over the elephant trunk technique in that it completes
the procedure within a single operation.
In acute type A dissection, the entire intimal tear resection
is desirable to achieve a good fate of the remaining dissected
aorta.18 However, extending the procedure to the aortic arch
could be associated with increasing mortality.18 In our series,
the mortality in acute dissection is satisfactorily low (6.9%),
and this could relate to the fact that this procedure could
achieve total arch repair without manipulating more distally
to the left common carotid artery, which facilitates the control
of bleeding.
Postoperative occurrence of vocal cord paralysis after
aortic surgery is considered to be an independent predictor
of pulmonary complications and leads to a longer duration
of hospital stay.19 Even with preservation of the recurrent
laryngeal nerve, vocal cord paralysis occurs in 21.9%
to 32% of aortic arch operations and in most cases does
not return to normal movement.20 Our procedure does not
require resection distally to the left artery, and it has the
advantage of avoiding recurrent nerve injury. Postoperative
vocal cord paralysis was observed in 9.5%, and 58% of
them had fully recovered during hospitalization. Mechani-
cal ventilation for more than 72 hours was required in
20.0% in our series and could be low in comparison with
other series of aortic arch replacement through a left thora-
cotomy (36–50%).21,22 These results suggest that the open
stent-grafting technique could contribute to reduced postop-
erative respiratory failure.
Spinal cord ischemia is a devastating complication of
aortic surgery. Our series showed 3 (2.4%) cases of paraple-
gia and 5 (3.9%) of paraparesis. Among the 3 patients with
paraplegia, 2 had intraoperatively hypotensive perfusion of
the lower body associated with stent graft stenosis. Inasmuch
as hypotension is widely known to be a risk factor for the
development of spinal cord ischemia,23 stent graft stenosis
is an important pitfall of this procedure. Designing the stent
graft carefully is mandatory when custom-made stent grafts
are used.
Among the 5 cases of temporal paraparesis, 2 were type A
acute dissections with preoperative malperfusion. Both of
them had a clotted false chamber and severely narrowed
true chamber in the descending aorta associated with hypo-
perfusion of the visceral arteries and lower extremity, which
raised concern about the occurrence of spinal cord ischemia.
The remaining 3 cases except for the hypoperfusion cases
were associated with a history of abdominal aortic repair.
From 1997, we started to administer CSFD before the oper-
ation in cases of previous thoracoabdominal or abdominalne 2008
Shimamura et al Surgery for Acquired Cardiovascular Disease
A
CDaortic repair. No spinal cord ischemia was observed since
then except the 2 cases of acute type A dissection with preop-
erative malperfusion.
In our study, survival at 1, 5, and 8 years was 81.1%,
63.3%, and 53.7%, respectively. Long-term results of
extended aortic arch repair are not well described, but our
result is comparable with those of other series of simple aortic
arch replacement (5-year survival 46%–79%).23-25
Despite encouraging early results, there are few reports
describing long-term results of endovascular stent graft
repair. Demers and his colleagues26 reported in their study
of 103 TEVARs for descending thoracic aorta that freedom
from endoleak was 78%, 64%, and 50% at 1, 5, and 8 years,
respectively. Freedom from endoleak in this series was
98.0%, 91.1%, and 91.1% for 1, 5, and 8 years, respectively,
which could be superior to TEVAR. TEVAR is inevitably as-
sociated with some frequency of proximal type I endoleak in
the early and long-term follow-up periods, but this is avoid-
able in the open stent-grafting technique because the proxi-
mal end of the stent graft was sutured in a surgical fashion.
All 5 patients who had a late distal endoleak were success-
fully treated with additional TEVAR, and there have been
no secondary endoleaks.
Although shrinkage of the aneurysm sac after endovascu-
lar repair may be desirable, the persistence of the aneurysm
does not represent a failure because a stable aneurysm with-
out endoleak has not been linked to any untoward effects.27
On the other hand, sac enlargement implies increased
pressure within the aneurysm sac and should be treated
promptly. In our series, 3 aneurysms showed enlargement
on late follow-up and all of them were associated with type
I/type III endoleaks. Also, we have to consider that the inter-
costal arteries are opened to the excluded aneurysm (type II
endoleak) and this requires that the transected stump of the
aortic arch be sutured to the stent graft. Inasmuch as these
issues should be carefully studied, we perform postoperative
CT with contrast medium at the arterial phase and delayed
phase to detect endoleaks.
However, type I/type III endoleaks can be treated with
additional endovascular repair with a good result. According
to type II endoleak, Ohki and colleagues28 had reported
a study using an implantable wireless aneurysm pressure sen-
sor for endovascular repair of abdominal aorta. They showed
that the postexclusion pulse pressure was significantly
decreasing. In no patient in our series was trouble caused
by the pressure inside the aneurysm, such as continuous leak-
ing from ruptured aneurysm or enlargement of the aneurysm
with type II endoleak. From these results, the pressure inside
the aneurysm (endotension) could be low enough in the clin-
ical point of view.
Limitation of the Study
This is a retrospective cohort study, and the lack of a concur-
rent control group restricts direct comparison with total archThe Journal of Thorareplacement associated with left thoracotomy. For the precise
advantage of open stent-grafting technique to be elucidated,
a prospective case–control study would be required. This
study includes our earliest experience with stent grafting,
so both the technical immaturity and the lack of adequate spi-
nal protection could have caused spinal ischemia. Improved
stent graft design, delivery system, and consideration of
spinal protection could be associated with better outcomes.
Conclusion
In this study of 126 patients treated with an open stent-
grafting technique, satisfactory early results were obtained
in both aortic dissections and aortic arch aneurysms with dis-
tal extension to the descending aorta. Regarding long-term
outcomes, acceptable survival and good avoidance of aortic
arch–related death was obtained. The incidence of endoleaks
was satisfactorily low and the patients could be rescued by
additional endovascular repair. In aortic dissection, this pro-
cedure could obtain good clot formation and shrinkage of the
false lumen. These results suggest that the open stent-grafting
technique is a safe and effective procedure and might be
a good alternative to conventional prosthetic replacement
for aortic dissections and arch aneurysm with distal extension
to the descending aorta.
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Discussion
Dr John Elefteriades (New Haven, Conn). I congratulate the
authors on an outstanding paper on hybrid therapy for aortic arch
aneurysm. The number of patients is large, the follow-up is quite
complete, and the duration of follow-up is long. The mortality and
stroke rates are excellent. I do take issue with the underlying theme
of the paper, that a direct surgical approach to the aortic arch is to be
feared and avoided in favor of extra-anatomic and stent-graft1268 The Journal of Thoracic and Cardiovascular Surgery c Juntherapy. Direct approaches to the aortic arch are safe, durable, and
time tested. Many series, including our own recently presented ex-
perience, show stroke and mortality rates with the conventional ap-
proach that are very comparable with those in your presentation.
Also, our experience shows that the descending aorta is not com-
monly problematic, even in the long term, after successful type A
repair, raising doubt about whether adjunctive stent therapy in the
descending aorta is really necessary.
I have 3 questions. My first question has to do with early mortal-
ity. You list your hospital mortality as 3%, but by 6 months 19% of
the patients are dead. How did another 16% of the patients die within
6 months of hospital discharge? What was going on clinically and
radiographically with their aortas and their brains before death?
My second question has to do with anatomic morphology and se-
lection for operation. It appears that a large proportion of cases in
this paper are not really extended arch lesions, as the title indicates,
but rather typical type A and type B dissections. I am uncomfortable
with the classification of the large number of patients with chronic
type B dissection in this series as having ‘‘arch’’ lesions. Descending
dissections are nearly always limited to the region distal to the sub-
clavian artery. These lesions are well treated by a relatively straight-
forward resection via left thoracotomy on left atrial–femoral artery
bypass. With a clamp placed between the left carotid and left subcla-
vian arteries, one has excellent exposure for the proximal anastomo-
sis. Why did the authors classify these as arch lesions and perform
their complex extra-anatomic repair?
For the third question, let us consider the failures of therapy.
How do you explain the persistence or progressive enlargement of
the aneurysm in 25% of your patients?
Congratulations on an excellent presentation.
Dr Shimamura. Thank you, Dr Elefteriades, for your kind com-
ments and important questions.
Regarding the first question about mortality, the early mortality
included 3 patients with postoperative strokes, and we lost these 3
patients within 1 year. It could be said that we have lowered the qual-
ity of life of the patients postoperatively, but the death is not associ-
ated directly to the stent graft. Also, there is a patient who had an
fatal aortoesophageal fistula, as I showed in my slides. We lost
this patient after successful treatment for a ruptured aneurysm
however, this endoluminal treatment does not resect the whole aneu-
rysm, so this kind of problem needs more investigation. Most of the
late deaths are associated with the relatively high risk of the back-
ground of the patients. We introduced stent-graft treatment in
clinical use in 1993, and this is the very first in Japan. Many patients
with severe comorbidities were sent to our institution, and we have
to deal with these high-risk patients. This could explain the
relatively poor overall survival in the long term. However, we be-
lieve that avoidance of the aortic arch–related deaths is satisfactory.
Your second question concerned the indication for this proce-
dure. Yes, we include type B dissection for this procedure, but the
indication is only for the complication-specific treatment for type
B dissection. We undertook this procedure for the patient with
type B dissection who has a very proximal intimal tear near to the
subclavian artery. These tears cannot be treated with endovascular
repair. Of course, there are options to do graft replacement with
a left thoracotomy, but we think that closure of the intimal tear via
a median approach is compatible with this treatment, and the results
are satisfactory in our study.e 2008
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an extension distally, and it was thought to be difficult to treat that
extension with conventional treatment via a median sternotomy.
Our series contains about 20% of patients who have a relatively prox-
imal location of the distal end of the aneurysms, and these could be
treated with traditional surgical repair. However, this procedure has
an advantage even in these aneurysms, because with the stent graft
you can alternate your distal anastomosis and manipulate only in the
proximal arch. This could be a very easy way to control the bleeding.
Dr BruceW. Lytle (Cleveland, Ohio).Regardless of the specific
indications for how often you do a debranching or whether this is
just an extension of a conventional arch repair, the concept of put-
ting in a stent graft during an open aortic operation, perhaps to
extend it to the descending aorta, makes a lot of sense. We certainly
have tried to do this. One of the things I have been really disap-
pointed in is the lack of response of our industrial partners to thisThe Journal of Thoraissue. We have tried to get a number of the companies interested
in making devices specifically for the purpose of being put in at
the time of surgery. They just cannot seem to get this.
The way you wrap the string around the graft is very clever, but
are you still doing it that way after 14 years? Has there not been
some company that has agreed to manufacture that on sort of
a prospective basis?
Dr Shimamura. We do not use the sheath to deliver the stent
graft, but we have no company that makes this kind of commercially
available stent graft. I hear that that kind of device is available in
Germany, and I think the production of such a device could expand
this technique widely.
Dr Lytle. I invite our colleagues to help our industrial partners to
understand that we are interested in this, because regardless of the
specific indication, there is no doubt that this concept will have
some degree of usefulness.cic and Cardiovascular Surgery c Volume 135, Number 6 1269
